Correlation Between Bristol Myers and LMF Acquisition

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Bristol Myers and LMF Acquisition at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bristol Myers and LMF Acquisition into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bristol Myers Squibb and LMF Acquisition Opportunities, you can compare the effects of market volatilities on Bristol Myers and LMF Acquisition and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bristol Myers with a short position of LMF Acquisition. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bristol Myers and LMF Acquisition.

Diversification Opportunities for Bristol Myers and LMF Acquisition

0.45
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Bristol and LMF is 0.45. Overlapping area represents the amount of risk that can be diversified away by holding Bristol Myers Squibb and LMF Acquisition Opportunities in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on LMF Acquisition Oppo and Bristol Myers is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bristol Myers Squibb are associated (or correlated) with LMF Acquisition. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of LMF Acquisition Oppo has no effect on the direction of Bristol Myers i.e., Bristol Myers and LMF Acquisition go up and down completely randomly.

Pair Corralation between Bristol Myers and LMF Acquisition

Considering the 90-day investment horizon Bristol Myers is expected to generate 14.39 times less return on investment than LMF Acquisition. But when comparing it to its historical volatility, Bristol Myers Squibb is 5.83 times less risky than LMF Acquisition. It trades about 0.07 of its potential returns per unit of risk. LMF Acquisition Opportunities is currently generating about 0.17 of returns per unit of risk over similar time horizon. If you would invest  2.14  in LMF Acquisition Opportunities on December 28, 2024 and sell it today you would earn a total of  2.25  from holding LMF Acquisition Opportunities or generate 105.14% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Bristol Myers Squibb  vs.  LMF Acquisition Opportunities

 Performance 
       Timeline  
Bristol Myers Squibb 

Risk-Adjusted Performance

Modest

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Bristol Myers Squibb are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal primary indicators, Bristol Myers may actually be approaching a critical reversion point that can send shares even higher in April 2025.
LMF Acquisition Oppo 

Risk-Adjusted Performance

Good

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in LMF Acquisition Opportunities are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. In spite of fairly uncertain fundamental indicators, LMF Acquisition showed solid returns over the last few months and may actually be approaching a breakup point.

Bristol Myers and LMF Acquisition Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Bristol Myers and LMF Acquisition

The main advantage of trading using opposite Bristol Myers and LMF Acquisition positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bristol Myers position performs unexpectedly, LMF Acquisition can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in LMF Acquisition will offset losses from the drop in LMF Acquisition's long position.
The idea behind Bristol Myers Squibb and LMF Acquisition Opportunities pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.

Other Complementary Tools

Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing